A Study to Evaluate Safety and Efficacy of PBK_M2101

Clinical trial NCT05923918 · UNKNOWN

Trial details

NCT number: NCT05923918
Sponsor: Pharmbio Korea Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Intestinal Disease Colonic Diseases Gastrointestinal Disease Digestive System Disease

Start date: 2023-06-01
Primary completion: 2024-05-01
Enrollment: 246

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.